Terms: = Breast cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Clinical Outcome
24 results:
1. Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer.
Han SH; Kim M; Chung YR; Woo JW; Choi HY; Park SY
Sci Rep; 2022 Nov; 12(1):20367. PubMed ID: 36437379
[TBL] [Abstract] [Full Text] [Related]
2. The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and clinical Implications.
Nascimento C; Gameiro A; Correia J; Ferreira J; Ferreira F
Cells; 2022 Aug; 11(16):. PubMed ID: 36010653
[TBL] [Abstract] [Full Text] [Related]
3. The clinical relevance of humoral immune responses to Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 and expression of Globo H in metastatic breast cancer.
Hung JT; Chen IJ; Ueng SH; Huang CS; Chen SC; Chen MY; Lin YC; Lin CY; Campbell MJ; Rugo HS; Yu AL
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35732348
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers.
Woo JW; Chung YR; Kim M; Choi HY; Ahn S; Park SY
Cancer Immunol Immunother; 2021 May; 70(5):1365-1378. PubMed ID: 33146829
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast.
Jamiyan T; Kuroda H; Yamaguchi R; Nakazato Y; Noda S; Onozaki M; Abe A; Hayashi M
Breast Cancer; 2020 Sep; 27(5):880-892. PubMed ID: 32222891
[TBL] [Abstract] [Full Text] [Related]
6. Connecting blood and intratumoral T
Wang L; Simons DL; Lu X; Tu TY; Solomon S; Wang R; Rosario A; Avalos C; Schmolze D; Yim J; Waisman J; Lee PP
Nat Immunol; 2019 Sep; 20(9):1220-1230. PubMed ID: 31285626
[TBL] [Abstract] [Full Text] [Related]
7. foxp3 gene polymorphism is associated with breast cancer in Iranian patients.
Arabpour F; Shafizad A; Rahimzadeh M; Norouzan M; Naderi N
Exp Oncol; 2018 Dec; 40(4):309-314. PubMed ID: 30593749
[TBL] [Abstract] [Full Text] [Related]
8. Functional heterogeneity of circulating T regulatory cell subsets in breast cancer patients.
Ostapchuk YO; Perfilyeva YV; Kustova EA; Urazalieva NT; Omarbaeva NA; Talaeva SG; Belyaev NN
Breast Cancer; 2018 Nov; 25(6):687-697. PubMed ID: 29797233
[TBL] [Abstract] [Full Text] [Related]
9. Infiltration of γδ T cells, IL-17+ T cells and foxp3+ T cells in human breast cancer.
Allaoui R; Hagerling C; Desmond E; Warfvinge CF; Jirström K; Leandersson K
Cancer Biomark; 2017 Dec; 20(4):395-409. PubMed ID: 29060923
[TBL] [Abstract] [Full Text] [Related]
10.
Banin Hirata BK; Losi Guembarovski R; Vitiello GAF; Guembarovski AL; Brajão de Oliveira K; Watanabe MAE
Dis Markers; 2017; 2017():6359603. PubMed ID: 28713192
[No Abstract] [Full Text] [Related]
11. Putative Biomarkers of Response to Treatment in breast cancer Patients: A Pilot Assay.
Rico MJ; Perroud HA; Herrera C; Alasino CM; Roggero EA; Pezzotto SM; Nocito AL; Rozados VR; Scharovsky OG
Cancer Invest; 2017 Jul; 35(6):377-385. PubMed ID: 28426268
[TBL] [Abstract] [Full Text] [Related]
12. Higher densities of foxp3
Yeong J; Thike AA; Lim JC; Lee B; Li H; Wong SC; Hue SS; Tan PH; Iqbal J
Breast Cancer Res Treat; 2017 May; 163(1):21-35. PubMed ID: 28233108
[TBL] [Abstract] [Full Text] [Related]
13. The Prognostic Value of Tumor-Infiltrating Lymphocytes in breast cancer: A Systematic Review and Meta-Analysis.
Mao Y; Qu Q; Chen X; Huang O; Wu J; Shen K
PLoS One; 2016; 11(4):e0152500. PubMed ID: 27073890
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis.
Yu X; Zhang Z; Wang Z; Wu P; Qiu F; Huang J
Clin Transl Oncol; 2016 May; 18(5):497-506. PubMed ID: 26459255
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic significance of tumor-infiltrating CD8+ and foxp3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.
Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T
Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640
[TBL] [Abstract] [Full Text] [Related]
16. Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral foxp3+ Tregs.
Demir L; Yigit S; Ellidokuz H; Erten C; Somali I; Kucukzeybek Y; Alacacioglu A; Cokmert S; Can A; Akyol M; Dirican A; Bayoglu V; Sari AA; Tarhan MO
Clin Exp Metastasis; 2013 Dec; 30(8):1047-62. PubMed ID: 23836289
[TBL] [Abstract] [Full Text] [Related]
17. foxp3-positive regulatory T lymphocytes and epithelial foxp3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.
Lal A; Chan L; Devries S; Chin K; Scott GK; Benz CC; Chen YY; Waldman FM; Hwang ES
Breast Cancer Res Treat; 2013 Jun; 139(2):381-90. PubMed ID: 23712790
[TBL] [Abstract] [Full Text] [Related]
18. Tumour-infiltrating foxp3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.
West NR; Kost SE; Martin SD; Milne K; Deleeuw RJ; Nelson BH; Watson PH
Br J Cancer; 2013 Jan; 108(1):155-62. PubMed ID: 23169287
[TBL] [Abstract] [Full Text] [Related]
19. Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.
Ma C; Zhang Q; Ye J; Wang F; Zhang Y; Wevers E; Schwartz T; Hunborg P; Varvares MA; Hoft DF; Hsueh EC; Peng G
J Immunol; 2012 Nov; 189(10):5029-36. PubMed ID: 23034170
[TBL] [Abstract] [Full Text] [Related]
20. Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression.
Sisirak V; Faget J; Gobert M; Goutagny N; Vey N; Treilleux I; Renaudineau S; Poyet G; Labidi-Galy SI; Goddard-Leon S; Durand I; Le Mercier I; Bajard A; Bachelot T; Puisieux A; Puisieux I; Blay JY; Ménétrier-Caux C; Caux C; Bendriss-Vermare N
Cancer Res; 2012 Oct; 72(20):5188-97. PubMed ID: 22836755
[TBL] [Abstract] [Full Text] [Related]
[Next]
